Barclays PLC Ani Pharmaceuticals Inc Call Options Transaction History

Barclays PLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2018 Feb 14, 2019	SELL	$41.17 - $56.44 $8,234 - $11,288	-200 Reduced 9.09%	2,000 $90,000
Q3 2018 Nov 14, 2018	BUY	$52.95 - $71.34 $105,900 - $142,680	2,000 Added 1000.0%	2,200 $124,000
Q2 2018 Aug 14, 2018	SELL	$56.38 - $68.08 $22,552 - $27,232	-400 Reduced 66.67%	200 $13,000
Q1 2018 May 15, 2018	SELL	$56.98 - $72.41 $5,698 - $7,241	-100 Reduced 14.29%	600 $35,000
Q4 2017 Feb 14, 2018	BUY	$53.3 - $74.56 $31,980 - $44,736	600 Added 600.0%	700 $45,000
Q3 2017 Nov 14, 2017	BUY	$43.46 - $52.49 $4,346 - $5,249	100	100 $5,000

212

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $982M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.